<i>In silico</i> Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization.

导出 LinkOut

翻译打印收藏纠错

作者： Maurice,Michel ^[1] ; Evert J,Homan ^[1] ; Elisée,Wiita ^[1] ; Kia,Pedersen ^[1] ; Ingrid,Almlöf ^[1] ; Anna-Lena,Gustavsson ^[2] ; Thomas,Lundbäck ^[2] ; Thomas,Helleday ^[3] ; Ulrika,Warpman Berglund ^[1]

作者单位： Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. ^[1] Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. ^[2] Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden. ^[3] Department of Oncology and Metabolism, Sheffield Cancer Centre, University of Sheffield, Sheffield, United Kingdom. ^[4]

关键词 drug discovery druggability malachite green nudix workflow

DOI 10.3389/fchem.2020.00443

PMID 32548091

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in chemistry

2020年8卷

443页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

<i>In silico</i> Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization.

Frontiers in chemistry

相似文献

Frontiers in chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>In silico</i> Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization.

Frontiers in chemistry

相似文献

Frontiers in chemistry

相关期刊

检索历史清除